跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
思福妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ceftazidime and Avibactam Sodium for Injection
Approved
化学药品
Ceftazidime and Avibactam Sodium for Injection
Pfizer Ireland Pharmaceuticals
🇨🇳 National Medical Products Administration
Approval Date
Apr 3, 2024
Approval ID
8aKPrGjwltC
Company
Pfizer Ireland Pharmaceuticals
Type
化学药品
Approval Details
Approval Id
8aKPrGjwltC
Approval Number
国药准字HJ20190038
Generic Name
注射用头孢他啶阿维巴坦钠
Generic Name En
Ceftazidime and Avibactam Sodium for Injection
Trade Name
思福妥
Drug Type
化学药品
Dosage Form
注射剂
Strength
2.5g（C₂₂H₂₂N₆O₇S₂ 2.0g 与 C₇H₁₁N₃O₆S 0.5g）
Reg Date
2024-04-03
Expired Date
2029-04-02
Company Name
Pfizer Ireland Pharmaceuticals
Production Company Name
Acs Dobfar Spa
Company Detail Path
/organization/pfizer-ireland-pharmaceuticals
Production Company Detail Path
/organization/acs-dobfar-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 3, 2024
Approval ID
8aKPrGjwltC
Type
化学药品
Back to NMPA Approvals
